Literature DB >> 33429800

Psychometric validation of a patient-reported outcome questionnaire (Qualipsosex) assessing the impact of psoriasis and psoriatic arthritis on patient perception of sexuality.

Eric Lespessailles1,2, Emmanuel Mahé3, Ziad Reguiai4, Edouard Begon5, François Maccari6, Nathalie Beneton7, Guillaume Chaby8, Carole Rosenberg9, Emmanuelle Dernis10, Fabienne Roux11, Isabelle Henry-Desailly12, Bénédicte Charles13, Cyril Ferdynus14,15, Marc Marty16, Eric Esteve2,17.   

Abstract

ABSTRACT: Psoriasis (Pso) and psoriatic arthritis (PsA) frequently have a negative impact on patients' sexual health. We have developed a specific questionnaire assessing the impact of Pso and PsA on patient perception of sexuality: the QualipsoSex Questionnaire (QSQ). The aim of the present study was to further validate this questionnaire by checking its psychometric properties including validity, reliability, and responsiveness.A cross sectional observational study with a longitudinal component for responsiveness and test-retest reliability was performed in 12 centers in France including 7 dermatologists and 5 rheumatologists. Psychometric properties were examined according to the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) check-list.At baseline, 114 patients had Pso and 35 patients had PsA including 17 peripheral arthritis, 4 axial disease, 13 patients with both axial disease and peripheral arthritis and one patient with an undifferentiated phenotype. The mean Pso Area and Severity Index score was 12.5. Genital organs were involved in 44.7% of Pso cases. Internal consistency, construct validity, and reliability were good with Cronbach's α coefficient, measure of sampling adequacy and intraclass correlation coefficient respectively at 0.87, 0.84, and 0.93. The QSQ also demonstrated acceptable sensitivity to change.The QSQ has demonstrated good psychometric properties fulfilling the validation process relative to the recommendations of the COSMIN check list. The QSQ is simple to score and may hopefully be valuable in clinical practice and in clinical trials.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33429800      PMCID: PMC7793412          DOI: 10.1097/MD.0000000000024168

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  31 in total

1.  Convergent and discriminant validation by the multitrait-multimethod matrix.

Authors:  D T CAMPBELL; D W FISKE
Journal:  Psychol Bull       Date:  1959-03       Impact factor: 17.737

Review 2.  Psoriatic Arthritis.

Authors:  Christopher T Ritchlin; Robert A Colbert; Dafna D Gladman
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

3.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

4.  Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior.

Authors:  D V Cicchetti; S A Sparrow
Journal:  Am J Ment Defic       Date:  1981-09

5.  Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.

Authors:  Tiffany Kwok; Janet E Pope
Journal:  J Rheumatol       Date:  2010-03-15       Impact factor: 4.666

Review 6.  Psoriasis.

Authors:  Wolf-Henning Boehncke; Michael P Schön
Journal:  Lancet       Date:  2015-05-27       Impact factor: 79.321

7.  Quality of life and sexual health in patients with genital psoriasis.

Authors:  K A P Meeuwis; J A de Hullu; H P van de Nieuwenhof; A W M Evers; L F A G Massuger; P C M van de Kerkhof; M M van Rossum
Journal:  Br J Dermatol       Date:  2011-05-13       Impact factor: 9.302

8.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

Authors:  S Garrett; T Jenkinson; L G Kennedy; H Whitelock; P Gaisford; A Calin
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis.

Authors:  M Larsabal; S Ly; E Sbidian; M Moyal-Barracco; J-N Dauendorffer; N Dupin; M A Richard; O Chosidow; M Beylot-Barry
Journal:  Br J Dermatol       Date:  2018-11-01       Impact factor: 9.302

Review 10.  Qualifying unmet needs and improving standards of care in psoriatic arthritis.

Authors:  Philip Helliwell; Laura Coates; Vinod Chandran; Dafna Gladman; Maarten de Wit; Oliver FitzGerald; Arthur Kavanaugh; Vibeke Strand; Philip J Mease; Wolf-Henning Boehncke; Richard G Langley; Ennio Lubrano; Mara Maccarone; Hendrik Schulze-Koops; Corinne Miceli-Richard; Ruben Queiro
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-12       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.